Skip to main content



 Third Annual Conference on Brain Metastases
August 19-20, 2021
A Virtual Conference

Register Now

Join the Society for Neuro-Oncology, and the AANS/CNS Section on Tumors, for the 3rd Annual Conference on Brain Metastases hosted virtually August 19-20, 2021. Click here to view the program for the conference.

Registration for the conference is open now. Please click here to register today.

Who Should Attend
Neuro-oncologist, medical oncologist, neurosurgeons, radiation oncologist, radiologist, physicians/scientists, clinical and laboratory trainees, allied health professionals, pharmacists, and other medical professionals with an interest in metastatic disease.

Learning Objectives
  • Discuss all available treatment options for management of LMD patients. 
  • Identify methods to assess QOL and any factors that may contribute to a decline in QOL.  
  • Summarize unique issues in the design of clinical trials for brain metastases. 
  • Recognize LITT as a treatment option for brain metastases. 
  • Identify immunotherapy options for treatment of brain metastases.
Topics that will be covered within the program are:  
  • Molecular Biomarkers
  • Significant Advances in Brain Metastases
  • Multimodality Treatment of Brain Metastases
  • Radiation in the Management of Brain Metastases
  • Tumor Board Discussion
  • Imaging Biomarkers
  • Radiation in the Management of Brain Metastases
  • Neurocognition and Quality of Life Considerations
  • Role of Systemic Therapy in the Management of Brain Metastases
  • Clinical Trial Panel Discussion
    CME Credits
    SNO is currently seeking CME credits for this conference. For CME Content, click here.  

    Evolving Role of Immunotherapy for Brain Metastases
    Kim Margolin 
    UW School of Medicine 

    Confirmed Speakers
    The list of speakers are currently online. The abstract presenters are currently not included in this list.  To view the current list of speakers, please click here.  


    The abstract submission deadline has passed. The conference organizers welcome the submission of original research on the following topics:
    • Basic Science
    • Leptomeningeal Disease
    • Clinical Trials
    • Medical Therapy (Chemotherapy and Immunotherapy)
    • Multimodality
    • Radiation
    • Surgery
    • Other

      Accepted abstracts will be published in Neuro-Oncology Advances
    What to Expect
    • Lectures, Q&A sessions, and electronic posters.  
    • Live activities to earn AMA PRA Category 1 Credits™  
    • Accepted abstracts to be published in SNO's journal, Neuro-Oncology Advances
    Scientific Program Co-Chairs
    Adrienne Boire 
    Memorial Sloan Kettering Cancer Center

    Paul Kongkham
    University of Toronto

    Rohan Ramakrishna
    Weill Cornell Medicine

    David Shultz
    University of Toronto